BUSINESS
US 10-year yield: Trump 2.0’s favourite metric – What it means for the markets
While lower treasury yields are positive for USD/INR & Indian equities, there is a risk that if trade/investment related uncertainty extends equity markets can be negatively impacted
BUSINESS
SRF: Sequential recovery in chemicals likely to gather strength
While competition from China remains a key variable to watch, SRF represents a niche export sector player which can outperform
BUSINESS
HEG: Better positioned for the steel investment cycle in the US
The company should benefit from the structural trend of decarbonisation in the steel industry
BUSINESS
Trump Tariff – How much can it hurt Indian pharma?
The first order impact will be a slow market share gain from innovators after a generic launch
BUSINESS
Syngene: Conversion of pilot projects to long-term contracts a big positive
The company remains a strong play on the global China-switch strategy
BUSINESS
Galaxy Surfactants: Weak show signals more pain for the FMCG sector
A pickup in domestic urban consumption, end of de-stocking in general trade, and the pricing trajectory of fatty alcohol are key variables to watch for.
BUSINESS
Metal prices to melt further on Trump’s fresh tariff levy
Indian companies may face sustained profitability pressure though the extent may vary
BUSINESS
Medanta: New facilities gradually stabilising; remain constructive
Encouraged by the demand-supply gap in healthcare needs in the hinterland, the company continues to add bed capacities
BUSINESS
Divi’s Lab: Operating leverage lifts margin profile
While pricing erosion remains a challenge for generic APIs, new opportunities for generic molecules will unfold in FY26. A lot of drug developments held up during COVID-19 are now getting fast-tracked
BUSINESS
Trade war 2.0: How should investors position themselves when volatility is the only constant?
Investors should focus on sectors that have strong earnings visibility with solid policy backdrop
BUSINESS
Navin Fluorine: Ramp-up in speciality strengthens outlook
An uptick in margins was a major surprise in Q3FY25. A strong order book, the pickup in the specialty segment, and guidance for a stable margin augur well for the company
BUSINESS
Agriculture: Sowing the seeds for more reforms
The budget aims at addressing the rural unemployment issue while ensuring sustainable farming
BUSINESS
Ami Organics: CDMO business brightens growth outlook
Apart from the expected growth in the CDMO and pharma businesses, the com-pany expects an uptick in the semiconductor business in FY26.
BUSINESS
Fed rate status quo marks 'wait and watch' as Trump 2.0 begins
Overriding concern over tariffs though key rate determinants appear to be in control
BUSINESS
Dr Agarwal’s Health Care IPO: A business model with vision, but at a pricey valuation
The eye-care service provider has an impressive execution track record, aided by both organic and inorganic initiatives
BUSINESS
Laurus Labs: Operating leverage playing out
In the coming quarters, performance in the areas of animal health, followed by formulations and crop science chemicals, can aid operating leverage
BUSINESS
Dr Reddy’s: Semaglutide opportunity is a key factor to watch
The long-term prospects for the company are evolving with product approvals in China, build-up of consumer healthcare franchise, and a biosimilar pipeline.
BUSINESS
Budget 2025: Agri sector expects more reforms, measures to boost rural income
Last year, the government set a target of bringing 1 crore farmers into natural farming through the National Mission on Natural Farming within two years. We believe more such steps could be in the offing.
BUSINESS
Will it be shock or celebration for Indian equities as Trump 2.0 kicks off?
The US President’s proposed policy steps can have a far-reaching impact on global markets, with the possibility of emerging markets seeing a relief rally
BUSINESS
RIL Q3 FY25: Consumer businesses drive performance, support outlook
Trends such as premiumisation and rising digital adoption will benefit its consumer-facing businesses while investments in clean energy will create a future growth driver
BUSINESS
Himadri Speciality: Valuation remains a sore point
Though the company is gradually diversifying into businesses like lithium-ion batteries and discovering applications for new end-markets, this journey faces gestation period and execution challenges.
BUSINESS
PCBL: Demand softness, inventory de-stocking weigh on the stock
Medium-term growth is likely to be driven by carbon black exports and the growing specialty exposure, though in short run volume off-take will remain soft.
BUSINESS
Laxmi Dental IPO: Can the public issue lend a big smile to investors?
A play on cutting-edge dental products; long-term investors can consider it post the IPO at more reasonable valuations.
BUSINESS
Medanta: Time to check out this healthcare theme
It is a play on the growing importance of regional health hubs in the northern and eastern states.
